Nancy Ham Disposes 600 USPH Shares; 941 Restricted Shares Still Vesting
Rhea-AI Filing Summary
Nancy Ham, a director of U S Physical Therapy, reported selling 600 shares of the company's common stock on 09/11/2025 at $81.71 per share. After the sale she beneficially owns 1,994 shares in total. That total includes 941 restricted shares granted under the company's Amended and Restated 2003 Stock Incentive Plan, with 470 shares scheduled to lapse (vest) on November 20, 2025 and 471 shares scheduled to lapse on March 6, 2026, subject to her continuing service as a director on those dates.
Positive
- None.
Negative
- None.
Insights
TL;DR Director sold a modest number of shares; significant portion of holdings are restricted and vest in near term.
The 600-share sale at $81.71 is a routine Section 16 disclosure showing a director reducing a small portion of her stake while retaining 1,994 shares. The filing clarifies that 941 shares are restricted and tied to continued board service with near-term vesting dates, which suggests remaining alignment with shareholders if she stays on the board. Transaction size relative to total holdings appears limited, indicating low immediate dilution or signaling risk. This is a single transaction report; no derivative activity or additional compensatory details were disclosed.
TL;DR Insider sale is modest and governed by standard equity plan vesting; not an obvious governance red flag.
The form identifies Nancy Ham as a director and shows sale activity plus planned vesting of restricted stock under the company's 2003 plan. The staggered vesting (Nov 20, 2025 and Mar 6, 2026) ties future ownership to continued directorship, which is typical for retention and alignment. The report was executed by an attorney-in-fact and contains no amendments or indications of a Rule 10b5-1 plan. From a governance perspective, this filing reads as routine director compensation realization rather than a disclosure of material corporate events.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $81.71 | $49K |
Footnotes (1)
- [object Object]